Skip to content

APOTHEEK WELLE: what changed

BE 0890.647.862NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€161,318
2024 · €151,044+€10,274
Equity
€671,332
2024 · €712,897-€41,565
Cash
€128,125
2024 · €28,805+€99,320
Balance sheet total
€1.2m
2024 · €1.1m+€94,160

Largest movements

2024 to 2025
Assets
  • Cash +€99,320

    up €99,320 (+345%), from €28,805 to €128,125

    mainly Other debts (+€182,104) and Net result for the year (+€161,318)

  • Tangible fixed assets -€42,856

    down €42,856 (-7.7%), from €559,077 to €516,220

    of which Land and buildings: -€38,519

  • Current investments +€30,824

    up €30,824 (+21.9%), from €141,000 to €171,824

  • Receivables within one year -€24,872

    down €24,872 (-15.1%), from €164,746 to €139,874

    of which Trade receivables: -€17,775

  • Stocks and contracts +€24,856

    up €24,856 (+12.3%), from €201,597 to €226,454

Equity and liabilities
  • Other debts +€182,104

    up €182,104 (+849%), from €21,446 to €203,549

  • Debts after one year -€61,824

    down €61,824 (-22.5%), from €274,517 to €212,693

  • Reserves -€41,565

    down €41,565 (-6.0%), from €692,897 to €651,332

Income statement
  • Gross operating margin +€34,835

    up €34,835 (+9.1%), from €381,028 to €415,863

  • Staff costs +€13,537

    up €13,537 (+11.4%), from €119,112 to €132,649

  • Taxes +€5,486

    up €5,486 (+8.3%), from €65,962 to €71,447

  • Depreciation +€4,334

    up €4,334 (+11.0%), from €39,224 to €43,558

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €151,044
Gross operating margin +€34,835
Staff costs -€13,537
Depreciation -€4,334
Other operating charges -€146
Financial income -€2,117
Financial charges +€1,057
Taxes -€5,486
Result 2025 €161,318
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€403,771
Investment -€40,576
Financing -€263,874
Cash 2024 €28,805
Net result for the year +€161,318
Depreciation +€43,558
Stocks and contracts -€24,856
Receivables within one year +€24,872
Deferred charges and accrued income +€2,162
Trade debts +€7,395
Tax, wage and social debts +€7,218
Other debts +€182,104
Investment in fixed assets (net) -€9,753
Current investments -€30,824
Debts after one year -€61,824
Current portion of long-term debt +€833
Contributions, distributions and other -€202,883
Cash 2025 €128,125
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,112,226 €1,206,386 +€94,160 +8.5%
Fixed assets 21/28 €564,177 €530,371 -€33,805 -6.0%
Tangible fixed assets 22/27 €559,077 €516,220 -€42,856 -7.7%
Land and buildings 22 €531,084 €492,565 -€38,519 -7.3%
Plant, machinery and equipment 23 €27,993 €22,991 -€5,002 -17.9%
Furniture and vehicles 24 - €664 +€664
Financial fixed assets 28 €5,100 €14,151 +€9,051 +177%
Current assets 29/58 €548,049 €676,015 +€127,966 +23.3%
Stocks and contracts in progress 3 €201,597 €226,454 +€24,856 +12.3%
Stocks 30/36 €201,597 €226,454 +€24,856 +12.3%
Amounts receivable within one year 40/41 €164,746 €139,874 -€24,872 -15.1%
Trade receivables 40 €156,156 €138,381 -€17,775 -11.4%
Other amounts receivable 41 €8,591 €1,493 -€7,098 -82.6%
Current investments 50/53 €141,000 €171,824 +€30,824 +21.9%
Cash at bank and in hand 54/58 €28,805 €128,125 +€99,320 +345%
Deferred charges and accrued income 490/1 €11,901 €9,739 -€2,162 -18.2%
Total equity and liabilities 10/49 €1,112,226 €1,206,386 +€94,160 +8.5%
Equity 10/15 €712,897 €671,332 -€41,565 -5.8%
Contributions 10/11 €20,000 €20,000 = 0.0%
Reserves 13 €692,897 €651,332 -€41,565 -6.0%
Distributable reserves 133 €692,897 €651,332 -€41,565 -6.0%
Amounts payable 17/49 €399,329 €535,055 +€135,725 +34.0%
Amounts payable after more than one year 17 €274,517 €212,693 -€61,824 -22.5%
Financial debts 170/4 €274,517 €212,693 -€61,824 -22.5%
Amounts payable within one year 42/48 €124,812 €322,362 +€197,549 +158%
Current portion of amounts payable after more than one year 42 €60,992 €61,824 +€833 +1.4%
Trade debts 44 €33,732 €41,126 +€7,395 +21.9%
Suppliers 440/4 €33,732 €41,126 +€7,395 +21.9%
Taxes, remuneration and social security 45 €8,644 €15,862 +€7,218 +83.5%
Taxes 450/3 €2,586 €9,291 +€6,705 +259%
Remuneration and social security 454/9 €6,058 €6,571 +€513 +8.5%
Other amounts payable 47/48 €21,446 €203,549 +€182,104 +849%
Remuneration, social security and pensions 62 €119,112 €132,649 +€13,537 +11.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €39,224 €43,558 +€4,334 +11.0%
Other operating charges 640/8 €2,971 €3,116 +€146 +4.9%
Gross operating margin 9900 €381,028 €415,863 +€34,835 +9.1%
Operating profit (loss) 9901 €219,720 €236,540 +€16,819 +7.7%
Financial income 75/76B €3,341 €1,225 -€2,117 -63.3%
Recurring financial income 75 €3,341 €1,225 -€2,117 -63.3%
Financial charges 65/66B €6,056 €4,999 -€1,057 -17.5%
Recurring financial charges 65 €6,056 €4,999 -€1,057 -17.5%
Profit (loss) for the period before taxes 9903 €217,005 €232,765 +€15,760 +7.3%
Income taxes 67/77 €65,962 €71,447 +€5,486 +8.3%
Profit (loss) for the period 9904 €151,044 €161,318 +€10,274 +6.8%
Profit (loss) for the period to be appropriated 9905 €151,044 €161,318 +€10,274 +6.8%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€884,726 to €1.1m

Midpoint €976,237 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €671,332
Capitalised earnings €1.1m to €1.5m
Indication €884,726 to €1.1m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€671,332
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€671,332

Capitalised earnings

net result for the year (9904)
2025
€161,318
2024
€151,044
2023
€148,850
2022
€182,883
excluding non-recurring income and charges
€173,144
2021
€45,809
Average result
€153,737
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.1m / €1.3m / €1.5m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 11 November 2026 via checked.be.